Cencora OUTPH Videos

  1. Cell And Gene Therapies – U.S. Payer Trends 5/20/2026

    Gain insights from U.S. payer interviews covering coverage processes, evidence requirements, and engagement strategies to accelerate market access from late-stage development through commercialization.

  2. The Transformative Potential Of AI In HEOR And Market Access 5/20/2026

    HEOR teams are under pressure to move faster without sacrificing rigor. Discover how AI accelerates evidence synthesis, fills data gaps, and supports living models that meet HTA transparency standards.

  3. The Evolving Policy Landscape: U.S. And EU Pricing And Access 5/20/2026

    U.S. and EU policy shifts are reshaping pricing, access, and launch strategy. Hear expert analysis on IRA, MFN, 340B, EU HTA Regulation, and the Biotech Act to stay ahead of 2025-2026 changes.

  4. Foundations And Implications For International Reference Pricing 5/14/2026

    Reforms like the U.S. Most Favored Nation model are intensifying pressure on global launch strategies. Understand the tactics that protect value while expanding access.

  5. The Growing Role Of Real-World Evidence 5/14/2026

    Regulators and HTA bodies are raising the bar on real-world evidence. Understand how JCAs, oncology registries, and EHR data are redefining what credible RWE looks like, and how to meet agency expectations.

  6. Understanding PRCI And Its Requirements 2/18/2026

    Navigating Health Canada's clinical information disclosure process takes real precision and preparation. Ensure your submission stays compliant, on schedule, and ready for review.

  7. Harmonizing Health Technology Assessment: PICO Consolidation Under The EU HTA Regulation 1/15/2026

    Discover how the EU HTA Regulation is redefining market access through PICO consolidation and learn strategic approaches to evidence generation, comparator selection, and the integration of real-world data.

  8. Insights For Innovation: AMCP Nexus 2025 Educational Videos 1/15/2026

    Explore our curated collection of expert-led educational sessions from AMCP Nexus 2025, covering key topics including updates on AMCP Format 5.0, strategic payer engagement tactics, AI-driven innovations, and more.

  9. Navigating The Regulatory Complexities Of Targeted Medicines In Oncology 8/22/2025

    Explore the strategic considerations for successfully navigating the regulatory complexities of targeted medicines. Learn about the challenges in translational medicine and key clinical development considerations.

  10. Transforming Drug Development With Statistical Science 8/12/2025

    Explore how statistical science and computational biology can accelerate drug development. Learn how innovative trial designs and Bayesian statistics can lead to more efficient and successful clinical trials.